![](/img/cover-not-exists.png)
152 Preclinical characterization of MM-151, an oligoclonal antibody therapeutic that targets EGFR by three distinct mechanisms of action
King, A., Sevecka, M., Gerami-Moayed, N., Burenkova, O., Kearns, J., Tan, G., Sloss, C., Bukhalid, R., Nielsen, U., Wolf, B.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70278-3
Date:
November, 2014
File:
PDF, 54 KB
english, 2014